✦ LIBER ✦

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

✍ Scribed by Raf Brouns; Evelien Heylen; Rishi Sheorajpanday; Johan L. Willemse; Jan Kunnen; Didier De Surgeloose; Dirk F. Hendriks; Peter P. De Deyn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboxypeptidase U (TAFIa) activity is i

✍ J. L. WILLEMSE; R. BROUNS; E. HEYLEN; P. P. DE DEYN; D. F. HENDRIKS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Predictors of early efficacy of thrombol

✍ Volkova, L.; Prazdnichkova, E.; Alasheev, A.; Shalagina, O.; Cyganenko, O. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Use of thrombolytic therapy in patients

✍ Eddy S. Lang 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Analysis of the Safety and Efficacy of I

✍ Lisboa, R. C.; Jovanovic, B. D.; Alberts, M. J. 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 317 KB

Risk of Thrombolytic Therapy for Acute I

✍ Shihab Masrur; Abdul R. Abdullah; Eric E. Smith; Renzo Hidalgo; Ahmed El-Ghandou 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Predictors of in-hospital mortality in p

✍ P.U. Heuschmann; P.L. Kolominsky-Rabas; J. Roether 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB